Customer Service
About Us
Quality Control
Privacy Policy

Search:

For:



Back to Pure NewsCaps Home 01/08/2007


Featured Articles

-Gastrointestinal Health: Products Designed to Support Digestion, GI Comfort, GI Integrity, Detoxification, Microflora Balance and Motility…*

-Digestion and Digestive Enzymes…*

-Anti-Fatigue Complex Product Information Sheet

New Products

-GI Health

-Fatigue Support

-Resveratrol EXTRA

Product Highlights

-Read more about our weekly product specials

-CoQ10 – NOW 15% LESS

Featured Abstracts

-Resveratrol has the potential to promote healthy glucose metabolism, mitochondrial health, motor function and lifespan as suggested in one study involving mice fed high-calorie diets…*

-Supplemental magnesium may help maintain healthy C-reactive protein metabolism…*

-Acetyl-l-carnitine relieves occasional mental fatigue and promotes mental focus…*

-Optimal zinc serum levels are associated with healthy T cell activation and antioxidant support in individuals experiencing symptoms of occasional fatigue…*

-Aloe supports immune and cellular health throughout the gastrointestinal tract…*

-Curcuma longa extract maintains healthy histamine response, moderates gastric secretions and protects gastric mucosa…*

Frequently Asked Questions

-Is there a difference between forms of magnesium chelates?

Quick Fact

-A note on Resveratrol




Randomized, double-blind, placebo-controlled trial of oral aloe vera gel for active ulcerative colitis

BACKGROUND: The herbal preparation, aloe vera, has been claimed to have anti-inflammatory effects and, despite a lack of evidence of its therapeutic efficacy, is widely used by patients with inflammatory bowel disease. AIM: To perform a double-blind, randomized, placebo-controlled trial of the efficacy and safety of aloe vera gel for the treatment of mildly to moderately active ulcerative colitis. METHODS: Forty-four evaluable hospital out-patients were randomly given oral aloe vera gel or placebo, 100 mL twice daily for 4 weeks, in a 2 : 1 ratio. The primary outcome measures were clinical remission (Simple Clinical Colitis Activity Index /= 3 points; response was defined as remission or improvement), Baron score, histology score, haemoglobin, platelet count, erythrocyte sedimentation rate, C-reactive protein and albumin. RESULTS: Clinical remission, improvement and response occurred in nine (30%), 11 (37%) and 14 (47%), respectively, of 30 patients given aloe vera, compared with one (7%) [P = 0.09; odds ratio, 5.6 (0.6-49)], one (7%) [P = 0.06; odds ratio, 7.5 (0.9-66)] and two (14%) [P < 0.05; odds ratio, 5.3 (1.0-27)], respectively, of 14 patients taking placebo. The Simple Clinical Colitis Activity Index and histological scores decreased significantly during treatment with aloe vera (P = 0.01 and P = 0.03, respectively), but not with placebo. Sigmoidoscopic scores and laboratory variables showed no significant differences between aloe vera and placebo. Adverse events were minor and similar in both groups of patients. CONCLUSION: Oral aloe vera taken for 4 weeks produced a clinical response more often than placebo; it also reduced the histological disease activity and appeared to be safe. Further evaluation of the therapeutic potential of aloe vera gel in inflammatory bowel disease is needed. Langmead L, Feakins RM, Goldthorpe S, et al. Aliment Pharmacol Ther. 2004;19(7):739-47.


For educational purposes only. Consult your physician for any health problems.

*These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.


home  |  disclaimer  |  privacy policy  |  contact us  |  about pure